Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Senna Mano

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Sao Paulo Medical Journal = Revista Paulista De Medicina|November 7, 2019
Mammary adenectomy followed by immediate reconstruction for treatment of patients with early-infiltrating breast carcinoma: a cohort studyAlfredo Carlos Simões Dornellas de Barros, Heloísa Andrade Carvalho, Felipe Eduardo Martins Andrade, et al.
Future Oncology (London, England)|December 22, 2023
Circulating microRNAs as potential biomarkers in triple-negative breast cancer: a translational research study of the NACATRINE trialAna Julia Aguiar Freitas, Caroline Rocha Nunes, Max Senna Mano, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 3, 2017
Multidisciplinary international survey of post-operative radiation therapy practices after nipple-sparing or skin-sparing mastectomyGustavo Nader Marta, Philip Poortmans, Alfredo C de Barros, et al.
AJR. American Journal of Roentgenology|March 25, 2016
MRI to Predict Nipple Involvement in Breast Cancer PatientsJosé Roberto Morales Piato, Roberta Dantas Jales Alves de Andrade, Luciano Fernandes Chala, et al.
Scientific Reports|December 4, 2023
Gene expression alterations predict the pathological complete response in triple-negative breast cancer exploratory analysis of the NACATRINE trialAna Julia Aguiar Freitas, Caroline Rocha Nunes, Max Senna Mano, et al.
Frontiers in Oncology|July 2, 2024
The somatic mutation profile of estrogen receptor-positive HER2-negative metastatic breast cancer in Brazilian patientsTomás Reinert, Fernanda Orpinelli do Rego, Matheus Costa E Silva, et al.
Cancer Treatment and Research Communications|January 30, 2023
Real-world treatment outcomes in HR+ HER2- metastatic breast cancer patients treated with CDK4/6 inhibitors: Results from a reference center in BrazilMarcello Moro Queiroz, Karina Perez Sacardo, Mauricio Fernando Ribeiro, et al.
Therapeutic Advances in Medical Oncology|January 5, 2023
Cost-effectiveness analysis of Oncotype DX from a Brazilian private medicine perspective: a GBECAM multicenter retrospective studyLeandro Jonata Carvalho Oliveira, Thais Baccili Cury Megid, Daniela Dornelles Rosa, et al.
Journal of the American College of Cardiology|March 16, 2018
Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity: The CECCY TrialMônica Samuel Avila, Silvia Moreira Ayub-Ferreira, Mauro Rogerio de Barros Wanderley, et al.
Breast (Edinburgh, Scotland)|August 6, 2025
Cancer outcomes in patients eligible for adjuvant cyclin-dependent kinase 4 and 6 inhibitors but spared adjuvant chemotherapy by Oncotype Dx: A multicenter retrospective GBECAM 0520 studyLeandro Jonata de Carvalho Oliveira, Daniela Dornelles Rosa, Artur Katz, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Sao Paulo Medical Journal = Revista Paulista De Medicina|November 7, 2019
Mammary adenectomy followed by immediate reconstruction for treatment of patients with early-infiltrating breast carcinoma: a cohort studyAlfredo Carlos Simões Dornellas de Barros, Heloísa Andrade Carvalho, Felipe Eduardo Martins Andrade, et al.
Future Oncology (London, England)|December 22, 2023
Circulating microRNAs as potential biomarkers in triple-negative breast cancer: a translational research study of the NACATRINE trialAna Julia Aguiar Freitas, Caroline Rocha Nunes, Max Senna Mano, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 3, 2017
Multidisciplinary international survey of post-operative radiation therapy practices after nipple-sparing or skin-sparing mastectomyGustavo Nader Marta, Philip Poortmans, Alfredo C de Barros, et al.
AJR. American Journal of Roentgenology|March 25, 2016
MRI to Predict Nipple Involvement in Breast Cancer PatientsJosé Roberto Morales Piato, Roberta Dantas Jales Alves de Andrade, Luciano Fernandes Chala, et al.
Scientific Reports|December 4, 2023
Gene expression alterations predict the pathological complete response in triple-negative breast cancer exploratory analysis of the NACATRINE trialAna Julia Aguiar Freitas, Caroline Rocha Nunes, Max Senna Mano, et al.
Frontiers in Oncology|July 2, 2024
The somatic mutation profile of estrogen receptor-positive HER2-negative metastatic breast cancer in Brazilian patientsTomás Reinert, Fernanda Orpinelli do Rego, Matheus Costa E Silva, et al.
Cancer Treatment and Research Communications|January 30, 2023
Real-world treatment outcomes in HR+ HER2- metastatic breast cancer patients treated with CDK4/6 inhibitors: Results from a reference center in BrazilMarcello Moro Queiroz, Karina Perez Sacardo, Mauricio Fernando Ribeiro, et al.
Therapeutic Advances in Medical Oncology|January 5, 2023
Cost-effectiveness analysis of Oncotype DX from a Brazilian private medicine perspective: a GBECAM multicenter retrospective studyLeandro Jonata Carvalho Oliveira, Thais Baccili Cury Megid, Daniela Dornelles Rosa, et al.
Journal of the American College of Cardiology|March 16, 2018
Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity: The CECCY TrialMônica Samuel Avila, Silvia Moreira Ayub-Ferreira, Mauro Rogerio de Barros Wanderley, et al.
Breast (Edinburgh, Scotland)|August 6, 2025
Cancer outcomes in patients eligible for adjuvant cyclin-dependent kinase 4 and 6 inhibitors but spared adjuvant chemotherapy by Oncotype Dx: A multicenter retrospective GBECAM 0520 studyLeandro Jonata de Carvalho Oliveira, Daniela Dornelles Rosa, Artur Katz, et al.
Pageof 3